in which the condensed system contains four or more hetero rings

Industry

CPC
C07D515/22

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00

Current Industry

C07D515/22in which the condensed system contains four or more hetero rings

Industries

Patents Grantslast 30 patents

Information Patent Grant
Preparation method for ecteinascidin compound and intermediate thereof
- Patent number 12,122,784
- Issue date Oct 22, 2024
- Brightgene Bio-Medical Technology Co., Ltd.
- Jiandong Yuan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged tricyclic carbamoylpyridone compounds and uses thereof
- Patent number 12,054,496
- Issue date Aug 6, 2024
- Gilead Sciences, Inc.
- Hang Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged tricyclic carbamoylpyridone compounds and uses thereof
- Patent number 12,024,528
- Issue date Jul 2, 2024
- Gilead Sciences, Inc.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...
- Patent number 11,866,450
- Issue date Jan 9, 2024
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumoral compounds
- Patent number 11,713,325
- Issue date Aug 1, 2023
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic indoles as Mcl-1 inhibitors
- Patent number 11,691,989
- Issue date Jul 4, 2023
- Ascentage Pharma (Suzhou) Co., Ltd.
- Hao Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mcl-1 inhibitors and methods of use thereof
- Patent number 11,472,816
- Issue date Oct 18, 2022
- Astrazeneca AB
- Alexander Hird
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 11,339,180
- Issue date May 24, 2022
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Preparation for natural product trabectedin
- Patent number 11,339,179
- Issue date May 24, 2022
- CE Pharm Co., Ltd.
- Dawei Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 11,332,480
- Issue date May 17, 2022
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator,...
- Patent number 11,066,417
- Issue date Jul 20, 2021
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MCL-1 inhibitors and methods of use thereof
- Patent number 10,889,594
- Issue date Jan 12, 2021
- Astrazeneca AB
- Alexander Hird
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic Gyrase inhibitors
- Patent number 10,865,216
- Issue date Dec 15, 2020
- Merck Sharp & Dohme Corp.
- Daniel Bensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 10,538,535
- Issue date Jan 21, 2020
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral compounds
- Patent number 10,442,820
- Issue date Oct 15, 2019
- Pharma Mar, S.A.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MCL-1 inhibitors and methods of use thereof
- Patent number 10,196,404
- Issue date Feb 5, 2019
- Astrazeneca AB
- Alexander Hird
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Conformationally constrained, fully synthetic macrocyclic compounds
- Patent number 10,017,481
- Issue date Jul 10, 2018
- Polyphor AG
- Daniel Obrecht
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzothiazole macrocycles as inhibitors of human immunodeficiency v...
- Patent number 9,944,656
- Issue date Apr 17, 2018
- ViiV Healthcare UK (No. 5) Limited
- B. Narasimhulu Naidu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic compounds as protein kinase inhibitors
- Patent number 9,808,466
- Issue date Nov 7, 2017
- Fundación Centro Nacional de Investigaciones Oncologicas Carlos III
- Joaquin Pastor Fernández
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of human immunodeficiency virus replication
- Patent number 9,663,536
- Issue date May 30, 2017
- ViiV Healthcare UK (No. 5) Limited
- B. Narasimhulu Naidu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic process for the manufacture of ecteinascidin compounds
- Patent number 9,428,524
- Issue date Aug 30, 2016
- Pharma Mar, S.A.
- Ma Jesús Martin López
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Polymer compound and electronic device using the same
- Patent number 9,396,831
- Issue date Jul 19, 2016
- Sumitomo Chemical Company, Limited
- Kenichiro Ohya
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amides
- Patent number 9,290,467
- Issue date Mar 22, 2016
- Hoffmann-La Roche Inc.
- Lilli Anselm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic compounds as protein kinase inhibitors
- Patent number 9,284,334
- Issue date Mar 15, 2016
- Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III
- Joaquin Pastor Fernández
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridazinone derivatives useful as glucan synthase inhibitors
- Patent number 8,232,274
- Issue date Jul 31, 2012
- Albany Molecular Research, Inc.
- Pauline C. Ting
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Difluoromethyl-containing macrocyclic compounds as hepatitis C viru...
- Patent number 8,211,891
- Issue date Jul 3, 2012
- Enanta Pharmaceuticals, Inc.
- Yonghua Gai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antitumoral derivatives of ET-743
- Patent number 8,076,337
- Issue date Dec 13, 2011
- Pharma Mar, S.A.
- Valentin Martinez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 7,989,438
- Issue date Aug 2, 2011
- Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.
- Immacolata Conte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of naturally occuring ecteinascidins and related compounds
- Patent number 7,947,671
- Issue date May 24, 2011
- Pharma Mar, S.A.
- Valentin Martinez Barrasa
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anititumoral ecteinascidin derivatives
- Patent number 7,919,493
- Issue date Apr 5, 2011
- Pharma Mar, S.A.
- Maria Flores
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMPROVED PROCESS FOR THE PREPARATION OF LURBINECTEDIN AND ITS MORPH...
- Publication number 20250002506
- Publication date Jan 2, 2025
- RK Pharma Inc.
- Jayaraman KANNAPPAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF
- Publication number 20240383911
- Publication date Nov 21, 2024
- BroadenBio Co., Ltd.
- Gongping DUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20240368189
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS F...
- Publication number 20240352039
- Publication date Oct 24, 2024
- NATCO PHARMA LIMITED
- Srinivasa Chary CHINTALAPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN
- Publication number 20240294549
- Publication date Sep 5, 2024
- NATCO PHARMA LIMITED
- Sunitha KOTHAMUNIREDDYGARI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTITUMORAL COMPOUNDS
- Publication number 20240166666
- Publication date May 23, 2024
- Pharma Mar, s.a.
- María del Carmen Cuevas Marchante
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20240166665
- Publication date May 23, 2024
- Dana-Farber Cancer Institute, Inc.
- NATHANAEL S. GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG ANTIBODY CONJUGATES
- Publication number 20240131180
- Publication date Apr 25, 2024
- Pharma Mar, s.a.
- Alfonso LATORRE LOZANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED F...
- Publication number 20230416276
- Publication date Dec 28, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230416275
- Publication date Dec 28, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A LYOPHILIZED PHARMACEUTICAL COMPOSITION
- Publication number 20230399344
- Publication date Dec 14, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME
- Publication number 20230399345
- Publication date Dec 14, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF
- Publication number 20230339972
- Publication date Oct 26, 2023
- GILEAD SCIENCES, INC.
- Hang Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
- Publication number 20230295104
- Publication date Sep 21, 2023
- Merck Patent GmbH
- Amir Hossain PARHAM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC 7-PYRAZOL-5-YL-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
- Publication number 20230265105
- Publication date Aug 24, 2023
- Janssen Pharmaceutica N.V.
- Frederik Jan Rita ROMBOUTS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC ETHER CONTAINING INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
- Publication number 20230250109
- Publication date Aug 10, 2023
- Janssen Pharmaceutica N.V.
- Benoît Christian Albert Ghislain DE BOECK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-LINKED MACROCYCLIC 7-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBIO...
- Publication number 20230234969
- Publication date Jul 27, 2023
- Janssen Pharmaceutica N.V.
- Frederik Jan Rita ROMBOUTS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBIT...
- Publication number 20230234965
- Publication date Jul 27, 2023
- Janssen Pharmaceutica N.V.
- Aldo PESCHIULLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Noscapinoid-producing Microbes and Methods of Making and Using the...
- Publication number 20230203551
- Publication date Jun 29, 2023
- The Board of Trustees of the Leland Stanford Junior University
- Christina D. Smolke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC COMPOUNDS
- Publication number 20230192720
- Publication date Jun 22, 2023
- ZENO MANAGEMENT, INC.
- Junhu Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of Alpha-4-beta-7 Integrin and MAdCAM
- Publication number 20230145835
- Publication date May 11, 2023
- 48HD Biopharma Inc.
- John J. DWYER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1
- Publication number 20230130109
- Publication date Apr 27, 2023
- Janssen Pharmaceutica N.V.
- Frederik Jan Rita ROMBOUTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS
- Publication number 20230121952
- Publication date Apr 20, 2023
- Inflazome Limited
- Matthew COOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYLIC SULFONYL DERIVATIVES MCL-1 INHIBITORS
- Publication number 20230029194
- Publication date Jan 26, 2023
- Janssen Pharmaceutica N.V.
- Frederik Jan Rita ROMBOUTS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYLIC INDOLE DERIVATIVES MCL-1 INHIBITORS
- Publication number 20230021562
- Publication date Jan 26, 2023
- Janssen Pharmaceutica N.V.
- Frederik Jan Rita ROMBOUTS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW SOLID STATE FORM OF LURBINECTEDIN
- Publication number 20230014782
- Publication date Jan 19, 2023
- Pharma Mar, s.a.
- Maria Del Mar Zarzuelo Alba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC FUSED PYRRAZOLES AS MCL-1 INHIBITORS
- Publication number 20220396587
- Publication date Dec 15, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Guozhi Tang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS
- Publication number 20220389031
- Publication date Dec 8, 2022
- Inflazome Limited
- Matthew COOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC INDOLES AS MCL-1 INHIBITORS
- Publication number 20220340595
- Publication date Oct 27, 2022
- Ascentage Pharma (Suzhou) Co., Ltd.
- Hao Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,...
- Publication number 20220315605
- Publication date Oct 6, 2022
- MSN LABORATORIES PRIVATE LIMITED, R&D CENTER
- Thirumalai Rajan SRINIVASAN
- C07 - ORGANIC CHEMISTRY

in which the condensed system contains four or more hetero rings

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Preparation method for ecteinascidin compound and intermediate thereof

Bridged tricyclic carbamoylpyridone compounds and uses thereof

Bridged tricyclic carbamoylpyridone compounds and uses thereof

Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...

Antitumoral compounds

Macrocyclic indoles as Mcl-1 inhibitors

Mcl-1 inhibitors and methods of use thereof

Antitumoral compounds

Preparation for natural product trabectedin

Antitumoral compounds

Modulators of cystic fibrosis transmembrane conductance regulator,...

MCL-1 inhibitors and methods of use thereof

Tricyclic Gyrase inhibitors

Antitumoral compounds

Antitumoral compounds

MCL-1 inhibitors and methods of use thereof

Conformationally constrained, fully synthetic macrocyclic compounds

Benzothiazole macrocycles as inhibitors of human immunodeficiency v...

Macrocyclic compounds as protein kinase inhibitors

Inhibitors of human immunodeficiency virus replication

Synthetic process for the manufacture of ecteinascidin compounds

Polymer compound and electronic device using the same

Cyclic amides

Macrocyclic compounds as protein kinase inhibitors

Pyridazinone derivatives useful as glucan synthase inhibitors

Difluoromethyl-containing macrocyclic compounds as hepatitis C viru...

Antitumoral derivatives of ET-743

Therapeutic compounds

Synthesis of naturally occuring ecteinascidins and related compounds

Anititumoral ecteinascidin derivatives

Patents Applicationslast 30 patents

IMPROVED PROCESS FOR THE PREPARATION OF LURBINECTEDIN AND ITS MORPH...

AZAINDAZOLE MACROCYCLE COMPOUNDS AND USES THEREOF

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

NOVEL CRYSTALLINE POLYMORPH OF LURBINECTEDIN AND IMPROVED PROCESS F...

AN IMPROVED PROCESS FOR THE PREPARATION OF TRABECTEDIN

ANTITUMORAL COMPOUNDS

COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOF

DRUG ANTIBODY CONJUGATES

LYOPHILIZED PHARMACEUTICAL COMPOSITION AND USES OF A CRYSTALLIZED F...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

A LYOPHILIZED PHARMACEUTICAL COMPOSITION

CRYSTALLIZED FORM OF LURBINECTEDIN AND METHOD OF MAKING THE SAME

BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF

MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES

MACROCYCLIC 7-PYRAZOL-5-YL-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1

MACROCYCLIC ETHER CONTAINING INDOLE DERIVATIVES AS INHIBITORS OF MCL-1

N-LINKED MACROCYCLIC 7-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBIO...

N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBIT...

Noscapinoid-producing Microbes and Methods of Making and Using the...

MACROCYCLIC COMPOUNDS

Modulators of Alpha-4-beta-7 Integrin and MAdCAM

MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1

COMPOUNDS

MACROCYLIC SULFONYL DERIVATIVES MCL-1 INHIBITORS

MACROCYLIC INDOLE DERIVATIVES MCL-1 INHIBITORS

NEW SOLID STATE FORM OF LURBINECTEDIN

MACROCYCLIC FUSED PYRRAZOLES AS MCL-1 INHIBITORS

MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

MACROCYCLIC INDOLES AS MCL-1 INHIBITORS

IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,...